Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Kang

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Diabetes Care|September 15, 2020
Therapy Escalation Following an Elevated HbA<sub>1c</sub> in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational AnalysisYing Xie, Jannah Baker, Tamara Young, et al.
Internal Medicine Journal|October 4, 2020
Risk factors for incident kidney disease in older adults: an Australian prospective population-based studyAmy Kang, Louisa Sukkar, Carinna Hockham, et al.
Diabetes Care|March 13, 2020
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 StudyLouisa Sukkar, Amy Kang, Carinna Hockham, et al.
Clinical Endocrinology|March 8, 2026
Improvement of Health-Related Quality of Life and Mental Health After Unilateral Adrenalectomy for Primary AldosteronismSybille Fuld, Christian Adolf, Georgiana Constantinescu, et al.
Diabetologia|August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS ProgramTamara K Young, Jing-Wei Li, Amy Kang, et al.
The Journal of Rheumatology|July 17, 2019
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with PolyangiitisMaria Weiner, Su Mein Goh, Aladdin J Mohammad, et al.
Diabetes, Obesity & Metabolism|June 19, 2024
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trialKathryn Cardoza, Amy Kang, Brendan Smyth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysisJack Kit-Chung Ng, Brendan Smyth, Mark R Marshall, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 8, 2021
Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure: A Randomized Controlled TrialAmy Kang, Ria Arnold, Martin Gallagher, et al.
JMIR Research Protocols|April 15, 2020
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort StudyCeline Foote, Carinna Hockham, Louisa Sukkar, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Diabetes Care|September 15, 2020
Therapy Escalation Following an Elevated HbA<sub>1c</sub> in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational AnalysisYing Xie, Jannah Baker, Tamara Young, et al.
Internal Medicine Journal|October 4, 2020
Risk factors for incident kidney disease in older adults: an Australian prospective population-based studyAmy Kang, Louisa Sukkar, Carinna Hockham, et al.
Diabetes Care|March 13, 2020
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 StudyLouisa Sukkar, Amy Kang, Carinna Hockham, et al.
Clinical Endocrinology|March 8, 2026
Improvement of Health-Related Quality of Life and Mental Health After Unilateral Adrenalectomy for Primary AldosteronismSybille Fuld, Christian Adolf, Georgiana Constantinescu, et al.
Diabetologia|August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS ProgramTamara K Young, Jing-Wei Li, Amy Kang, et al.
The Journal of Rheumatology|July 17, 2019
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with PolyangiitisMaria Weiner, Su Mein Goh, Aladdin J Mohammad, et al.
Diabetes, Obesity & Metabolism|June 19, 2024
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trialKathryn Cardoza, Amy Kang, Brendan Smyth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysisJack Kit-Chung Ng, Brendan Smyth, Mark R Marshall, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 8, 2021
Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure: A Randomized Controlled TrialAmy Kang, Ria Arnold, Martin Gallagher, et al.
JMIR Research Protocols|April 15, 2020
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort StudyCeline Foote, Carinna Hockham, Louisa Sukkar, et al.
Pageof 4